All News

Individuals who perceive themselves to be at a high risk of HIV are more likely to accept pre-exposure prophylaxis (PrEP) than their peers.

The FDA has approved sumatriptan nasal spray (Tosymra, Promius Pharma) for the acute treatment of migraine with or without aura in adults.

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.”

In a congressional hearing held on Capitol Hill today, the damaging impact of rising insulin prices was the centerpiece of a larger discussion on rising drug costs in the United States.

Top news of the day across the health care landscape.

Analysis shows prices among all insulin types and products increased steadily between 2012 and 2016.

Top news of the day across the health care landscape.

Two recent studies analyzed factors that impacted response to therapy in patients with multiple myeloma.

A prescription drug ad broadcast during the musical on television has set the stage for a larger conversation about patient access to preexposure prophylaxis medication.

Syphilis is a sexually transmitted infection that has increased significantly among pregnant women and newborns.

The FDA has approved the use of ibrutinib (Imbruvica®, AbbVie) in combination with obinutuzumab (Gazyva®) for adult patients with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Ibrutinub plus obinutuzumab is the first FDA-approved non-chemotherapy combination regimen for chronic lymphocytic lymphoma and small lymphocytic lymphoma.

Better strategies are needed to adequately identify and prevent opportunistic infections and related deaths in patients with advanced HIV.

Top news of the day across the health care landscape.

Can you solve the pharmaceutical mystery?

Top news of the day across the health care landscape.

Health Mart has named Nimesh Jhaveri, MBA, RPh, its new president.

Post-cure care for hepatitis C can reduce the risk of liver disease progression in those with advanced fibrosis and ongoing risk factors for liver injury.

Conducted by the FDA, an analysis follows a series of recalls for some generic versions of the angiotensin II receptor blocker (ARB) medicines containing nitrosamine impurities that do not meet the agency’s safety standards.

Selecting an accreditation agency should be determined by the local business environment and needs.

Top news of the week from Specialty Pharmacy Times.

Top news of the day across the health care landscape.

Rituximab is approved by the FDA for the treatment of adults with rheumatoid arthritis, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, pemphigus vulgaris, granulomatosis with polyangiitis and microscopic polyangiitis.

I firmly believe that overall pharmacy knowledge should increase over time.

Younger cancer survivors and those with high deductible private insurance plans experienced the greatest financial burden.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

Because high triglycerides have been associated with an increased risk for CVD, lowering this lab value should also reduce circulatory system risks.

A novel inhaled product was approved in late 2018 for Parkinson Disease.